Histotripsy: minimally invasive technology for prostatic tissue ablation in an in vivo canine model.

OBJECTIVES Symptoms of benign prostatic hyperplasia affect men increasingly as they age. Minimally invasive therapies for the treatment of benign prostatic hyperplasia continue to evolve. We describe histotripsy, a noninvasive, nonthermal, focused ultrasound technology for precise tissue ablation, and report the initial results of using histotripsy for prostatic tissue ablation in an in vivo canine model. METHODS An annular 18-element, 750-kHz, phased-array ultrasound system delivered high-intensity (22 kW/cm(2)), ultrasound pulses (15 cycles in 20 ms) at pulse repetition frequencies of 100 to 500 Hz to canine prostates. Eight lateral lobe and nine periurethral treatments were performed in 11 anesthetized dogs. Diagnostic ultrasound transducers provided in-line and transrectal imaging. Retrograde urethrography was performed before and after the periurethral treatments. After treatment, the prostates were grossly examined, sectioned, and submitted for histologic examination. RESULTS In the lateral lobe treatments, a well-demarcated cavity containing liquefied material was present at the ablation site. Microscopically, the targeted volume was characterized by the presence of histotripsy paste (debris, absent cellular structures). A narrow margin of cellular injury was noted, beyond which no tissue damage was apparent. The periurethral treatments resulted in total urethral ablation or significant urethral wall damage, with visible prostatic urethral defects on retrograde urethrography. Real-time ultrasound imaging demonstrated a dynamic hyperechoic zone at the focus, indicative of cavitation and suggesting effective tissue ablation. CONCLUSIONS The results of our study have shown that histotripsy is capable of precise prostatic tissue destruction and results in subcellular fractionation of prostate parenchyma. Histotripsy can also produce prostatic urethral damage and thereby facilitate drainage of finely fractionated material per urethra, producing immediate debulking.

[1]  Z. Xu,et al.  Controlled ultrasound tissue erosion , 2003, IEEE Symposium on Ultrasonics, 2003.

[2]  K McPherson,et al.  Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. , 1989, The New England journal of medicine.

[3]  C. Cain,et al.  Controlled ultrasound tissue erosion , 2003, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[4]  R. Ton,et al.  Threshold Ultrasonic Dosages for Structural Changes in the Mammalian Brain * , 2004 .

[5]  J Brian Fowlkes,et al.  Pulsed cavitational ultrasound: a noninvasive technology for controlled tissue ablation (histotripsy) in the rabbit kidney. , 2006, The Journal of urology.

[6]  C. Cain,et al.  Renal ablation by histotripsy--does it spare the collecting system? , 2008, The Journal of urology.

[7]  A T Cockett,et al.  Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. , 1989, The Journal of urology.

[8]  J. E. Parsons,et al.  Characterizing Pulsed Ultrasound Therapy for Production of Cavitationally‐Induced Lesions , 2005 .

[9]  J. E. Parsons,et al.  Refining histotripsy: defining the parameter space for the creation of nonthermal lesions with high intensity, pulsed focused ultrasound of the in vitro kidney. , 2007, The Journal of urology.

[10]  P. Walsh,et al.  The development of human benign prostatic hyperplasia with age. , 1984, The Journal of urology.

[11]  John T. Wei,et al.  Urologic diseases in America project: benign prostatic hyperplasia. , 2005, The Journal of urology.

[12]  C. Cain,et al.  Microbubble-enhanced cavitation for noninvasive ultrasound surgery , 2003, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[13]  C. Evans,et al.  Minimally invasive therapies for benign prostatic hyperplasia , 2002, World Journal of Urology.

[14]  J. Oesterling,et al.  The prevalence of prostatism: a population-based survey of urinary symptoms. , 1993, The Journal of urology.

[15]  C. Cain,et al.  Histotripsy of rabbit renal tissue in vivo: temporal histologic trends. , 2007, Journal of endourology.

[16]  M. Elhilali Minimally invasive therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia. , 2007, The Journal of urology.